![Amphista logo](/sites/default/files/styles/card/public/2022-04/Amphista%20Therapeutics%20logo%20B.png?h=8ac40672&itok=Kz3wuDEd)
Press release
University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.
Press release
University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.
Press release
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.
News
We have a bumper crop of promotions this year as part of the 2022 Annual Review process for academic staff.
Press release
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy.
News
The Drug Discovery Unit (DDU) is delighted to announce that Professor Ian Gilbert has been appointed to be the Head of the Drug Discovery Unit
News
Dr Michele Tinti recently participated in a biomedicine crowdsourced challenge instigated by DREAM Challenges. Michele was placed 10th out of almost 300 registered participants and 26 finalist teams.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein
Feature
Early career researchers in the School have received support from the Scottish Universities Life Sciences Alliance (SULSA) to establish new life sciences networks by providing funds towards the running of a network event.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
A deadly disease that can kill victims who may never know they were infected is to be targeted by University of Dundee scientists following a multi-million funding award.
News
UK Biobank recently announced the appointment of Professor Sir Michael Ferguson to its Board.
Press release
The University of Dundee is among the UK research organisations to benefit from a £118 million funding package to accelerate knowledge exchange, translation and commercialisation.
News
Professor Alessio Ciulli has been awarded a European Federation for Medicinal Chemistry and Chemical Biology Awards 2022.
Impact case study
Shaping the future of commercial drug development and driving global pharmaceutical investment.
Impact case study
Bringing about step-change in the diagnosis and treatment of neglected tropical diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Dr Xingui Liu has been awarded a Marie Skłodowska-Curie Fellowship to undertake research in the lab of Professor Alessio Ciulli in the newly established Centre for Targeted Protein Degradation (CeTPD).
Press release
The life-changing work of one of Scotland’s foremost scientific institutions is to continue following a multi-million-pound award.